Ticker brief

BAYRY BAYER AG-SPONSORED ADR

Consumer, Non-cyclical · Pharmaceuticals

last close
$13.84
1 day
+0.0%
14 days
-0.4%
mkt cap
·
signals 14d
9
authors 14d
5
crowd 14d
-0.6σ
Sentiment — last 14 days
daily mean sentiment, 2026-10-02 → 2026-10-08 · now +0.30 (−1 bearish … +1 bullish)
Who spoke5
authorgradetrader scoresignalsmean sent
@OzmosiHealthC·4+0.30
@MktBrain_USC+0.352+0.20
@USAnt_IDEAC-0.641+0.15
@LiveSquawkB·1+0.20
@csidetraderC+0.361+0.20
Recent signals9of 9 in 14d — receipts included
date (PT)authorsentwhat they saidsince thenreceipt
2026-10-08@OzmosiHealth+0.10Bayer announced an awareness partnership supporting its menopause treatment.—
2026-10-08@OzmosiHealth+0.10Bayer announced an awareness partnership supporting its menopause treatment.—
2026-10-08@OzmosiHealth+0.50FDA accepted Bayer's supplemental drug application for Kerendia.—
2026-10-08@OzmosiHealth+0.50FDA accepted Bayer's supplemental drug application for Kerendia.—
2026-10-07@MktBrain_US+0.20FDA accepted Bayer's application to expand Kerendia use to chronic kidney disease patients without diabetes.—
2026-10-05@csidetrader+0.20Reports Bayer's planned $2.2 billion Ohio drug-manufacturing investment.—
2026-10-05@LiveSquawk+0.20Bayer reportedly plans a $2.2 billion U.S. pharmaceutical plant amid tariff concerns.—
2026-10-04@USAnt_IDEA+0.15Reports Bayer will invest $2.2B in an Ohio drug-production campus creating 1,500 construction and 600 skilled jobs.—
2026-10-02@MktBrain_US+0.20WSJ reports Bayer will invest $2.2 billion to expand pharmaceutical manufacturing in the US.—

“Since then” = price move from the close on the signal's date (PT) to the latest close — what happened after they said it, not a backtest. A — means no trading session has closed since the signal yet. Sentiment is our extracted per-tweet score, −1…+1.